ArticleNaunyn-Schmiedeberg's archives of pharmacology2026

Postmarketing pharmacovigilance study of levothyroxine based on FDA adverse event reporting system (FAERS) and Mendelian randomization.

Bingyu Ma et al.PubMed ↗Publisher ↗

No numbers read from the abstract.